Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Salim S. Abdool Karim, Ph.D., M.Med., M.B.,Ch.B.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U2GPS001350 (ABDOOL KARIM, SALIM S) Sep 30, 2008 - Sep 29, 2014
    NIH
    CAPRISA AIDS TREATMENT PROGRAMME
    Role: Principal Investigator
  2. UM1AI069469 (ABDOOL KARIM, QUARRAISHA) Mar 1, 2007 - Nov 30, 2027
    NIH
    KwaZulu-Natal Clinical Trials Unit
    Role: Principal Investigator
  3. U01AI069469 (ABDOOL KARIM, SALIM S) Mar 1, 2007 - Jan 31, 2014
    NIH
    University of KwaZulu-Natal - CAPRISA HIV/AIDS Clinical Trials Unit
    Role: Principal Investigator
  4. R21TW006111 (ABDOOL KARIM, SALIM S) Sep 22, 2002 - Sep 21, 2003
    NIH
    Natal-Columbia Clinical AIDS/TB Training Program
    Role: Principal Investigator
  5. U19AI051794 (ABDOOL KARIM, SALIM S) Jul 1, 2002 - Jun 30, 2008
    NIH
    COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jassat W, Abdool Karim SS, Ozougwu L, Welch R, Mudara C, Masha M, Rousseau P, Wolmarans M, Selikow A, Govender N, Walaza S, von Gottberg A, Wolter N, Terrence Pisa P, Sanne I, Govender S, Blumberg L, Cohen C, Groome MJ. Trends in Cases, Hospitalization and Mortality Related to the Omicron BA.4/BA.5 Sub-Variants in South Africa. Clin Infect Dis. 2022 Dec 01. PMID: 36453094.
    Citations:    Fields:    
  2. Asare K, Andine T, Naicker N, Dorward J, Singh N, Spooner E, Andriesen J, Osman F, Ngcapu S, Vandormael A, Mindel A, Abdool Karim SS, Bekker LG, Gray G, Corey L, Tomita A, Garrett N. Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial. Clin Infect Dis. 2022 Oct 15. PMID: 36250382.
    Citations:    Fields:    
  3. Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, Cele S, Lustig G, Amoako D, Wolter N, Samsunder N, Sivro A, San JE, Giandhari J, Tegally H, Pillay S, Naidoo Y, Mazibuko M, Miya Y, Ngcobo N, Manickchund N, Magula N, Karim QA, von Gottberg A, Abdool Karim SS, Hanekom W, Gosnell BI, Lessells RJ, de Oliveira T, Moosa MS, Sigal A. Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection. Nat Commun. 2022 Oct 13; 13(1):6057. PMID: 36229444; PMCID: PMC9559132.
    Citations:    Fields:    
  4. Liebenberg LJP, Passmore JAS, Osman F, Jewanraj J, Mtshali A, Gerardo Garcia-Lerma J, Heneine W, Holder A, Archary D, Ngcapu S, Sivro A, Mansoor LE, Abdool Karim Q, Abdool Karim SS, McKinnon LR. Genital Immune Cell Activation and Tenofovir Gel Efficacy: A Case-Control Study. Clin Infect Dis. 2022 09 29; 75(6):1088-1091. PMID: 35142337.
    Citations:    Fields:    
  5. Mazibuko-Motau N, Sobia P, Xu J, Elsherbini JA, San JE, Lewis L, Mtshali A, Mzobe G, Ntuli L, Abdool Karim SS, Mansoor LE, Abdool Karim Q, Kwon DS, Archary D, Ngcapu S. Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women. Sci Rep. 2022 09 28; 12(1):16187. PMID: 36171447; PMCID: PMC9519742.
    Citations:    Fields:    Translation:HumansPHPublic Health
  6. Scheepers C, Kgagudi P, Mzindle N, Gray ES, Moyo-Gwete T, Lambson BE, Oosthuysen B, Mabvakure B, Garrett NJ, Abdool Karim SS, Morris L, Moore PL. Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies. PLoS Pathog. 2022 09; 18(9):e1010450. PMID: 36054228; PMCID: PMC9477419.
    Citations:    Fields:    Translation:HumansCells
  7. Mahomed S, Garrett N, Capparelli EV, Osman F, Harkoo I, Yende-Zuma N, Gengiah TN, Archary D, Samsunder N, Baxter C, Mkhize NN, Modise T, Carlton K, McDermott A, Moore PL, Karim QA, Barouch DH, Fast PE, Mascola JR, Ledgerwood JE, Morris L, Abdool Karim SS. Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention. J Infect Dis. 2022 08 26; 226(3):510-520. PMID: 35134995; PMCID: PMC9417124.
    Citations:    Fields:    
  8. Khan K, Lustig G, Bernstein M, Archary D, Cele S, Karim F, Smith M, Ganga Y, Jule Z, Reedoy K, Miya Y, Mthabela N, Magula NP, Lessells R, de Oliveira T, Gosnell BI, Abdool Karim S, Garrett N, Hanekom W, Bekker LG, Gray G, Blackburn JM, Moosa MS, Sigal A. Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2022 08 24; 75(1):e857-e864. PMID: 34893824; PMCID: PMC8689810.
    Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
  9. Abdool Karim SS, Devnarain N. Time to Stop Using Ineffective Covid-19 Drugs. N Engl J Med. 2022 08 18; 387(7):654-655. PMID: 36070715.
    Citations: 3     Fields:    Translation:Humans
  10. Asare K, Osman F, Ngcapu S, Vandormael A, Naicker N, Khanyile M, Mindel A, Abdool Karim SS, Tomita A, Garrett N. Burden of sexually transmitted infections from acute HIV infection among women in South Africa: Evidence from a prospective cohort study. Ann Epidemiol. 2022 Oct; 74:132-139. PMID: 35977656.
    Citations:    Fields:    Translation:Humans
  11. Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, Cele S, Lustig G, Amoako D, Wolter N, Samsunder N, Sivro A, San JE, Giandhari J, Tegally H, Pillay S, Naidoo Y, Mazibuko M, Miya Y, Ngcobo N, Manickchund N, Magula N, Karim QA, von Gottberg A, Abdool Karim SS, Hanekom W, Gosnell BI, Lessells RJ, de Oliveira T, Moosa MS, Sigal A. Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection. Nat Commun. 2022 08 10; 13(1):4686. PMID: 35948557; PMCID: PMC9364294.
    Citations: 44     Fields:    Translation:HumansCells
  12. Naicker N, Yende-Zuma N, Kharsany ABM, Shozi H, Nkosi D, Naidoo A, Garrett N, Abdool Karim SS. Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa. BMC Pregnancy Childbirth. 2022 Jul 26; 22(1):596. PMID: 35883114; PMCID: PMC9317085.
    Citations:    Fields:    Translation:HumansPHPublic Health
  13. Mansoor LE, Lewis L, Naicker CL, Harkoo I, Dawood H, Naidoo K, Gengiah TN, Samsunder N, Beesham I, Abdool Karim SS, Abdool Karim Q. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa. J Int AIDS Soc. 2022 07; 25(7):e25957. PMID: 35785472; PMCID: PMC9251857.
    Citations:    Fields:    Translation:HumansPHPublic Health
  14. Sheward DJ, Hermanus T, Murrell B, Garrett N, Abdool Karim SS, Morris L, Moore PL, Williamson C. HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies. J Virol. 2022 07 27; 96(14):e0032422. PMID: 35758668; PMCID: PMC9327685.
    Citations:    Fields:    Translation:HumansCells
  15. Khan K, Karim F, Cele S, Reedoy K, San JE, Lustig G, Tegally H, Rosenberg Y, Bernstein M, Jule Z, Ganga Y, Ngcobo N, Mazibuko M, Mthabela N, Mhlane Z, Mbatha N, Miya Y, Giandhari J, Ramphal Y, Naidoo T, Sivro A, Samsunder N, Kharsany ABM, Amoako D, Bhiman JN, Manickchund N, Abdool Karim Q, Magula N, Abdool Karim SS, Gray G, Hanekom W, von Gottberg A, Milo R, Gosnell BI, Lessells RJ, Moore PL, de Oliveira T, Moosa MS, Sigal A. Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature. 2022 07; 607(7918):356-359. PMID: 35523247; PMCID: PMC9279144.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  16. Abdool Karim SS, Baxter C, Abdool Karim Q. Advancing HIV prevention using tenofovir-based pre-exposure prophylaxis. Antivir Ther. 2022 04; 27(2):13596535211067589. PMID: 35499171.
    Citations:    Fields:    Translation:HumansPHPublic Health
  17. Lazarus JV, Abdool Karim SS, van Selm L, Doran J, Batista C, Ben Amor Y, Hellard M, Kim B, Kopka CJ, Yadav P. COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps. BMJ Glob Health. 2022 04; 7(4). PMID: 35474267; PMCID: PMC9044511.
    Citations:    Fields:    Translation:HumansPHPublic Health
  18. Abdool Karim SS. Public understanding of science: Communicating in the midst of a pandemic. Public Underst Sci. 2022 04; 31(3):282-287. PMID: 35491915.
    Citations:    Fields:    Translation:HumansPHPublic Health
  19. Hunter DJ, Abdool Karim SS, Baden LR, Farrar JJ, Hamel MB, Longo DL, Morrissey S, Rubin EJ. Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good. N Engl J Med. 2022 03 24; 386(12):1176-1179. PMID: 35196425.
    Citations: 3     Fields:    Translation:HumansCells
  20. Ngcobo S, Molatlhegi RP, Osman F, Ngcapu S, Samsunder N, Garrett NJ, Abdool Karim SS, Abdool Karim Q, McKinnon LR, Sivro A. Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression. Sci Rep. 2022 02 14; 12(1):2437. PMID: 35165387; PMCID: PMC8844050.
    Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
  21. Khan K, Karim F, Cele S, San JE, Lustig G, Tegally H, Rosenberg Y, Bernstein M, Ganga Y, Jule Z, Reedoy K, Ngcobo N, Miya Y, Mazibuko M, Mthabela N, Mhlane Z, Mbatha N, Giandhari J, Ramphal Y, Naidoo T, Manickchund N, Magula N, Karim SA, Gray G, Hanekom W, von Gottberg A, Milo R, Gosnell B, Lessells R, de Oliveira T, Moore P, Moosa YS, Sigal A. Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant. medRxiv. 2022 Jan 28. PMID: 34981076; PMCID: PMC8722619.
    Citations:    
  22. Gengiah TN, Abdool Karim Q, Harkoo I, Mansoor L, Zuma NY, Radebe P, Samsunder N, Baxter C, Maharaj B, Baum MM, Moss JA, Pozzetto B, Hankins C, Abdool Karim S. CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women. BMJ Open. 2022 Jan 06; 12(1):e052880. PMID: 34992111; PMCID: PMC8739430.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  23. Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, San JE, Cromer D, Scheepers C, Amoako DG, Karim F, Bernstein M, Lustig G, Archary D, Smith M, Ganga Y, Jule Z, Reedoy K, Hwa SH, Giandhari J, Blackburn JM, Gosnell BI, Abdool Karim SS, Hanekom W, von Gottberg A, Bhiman JN, Lessells RJ, Moosa MS, Davenport MP, de Oliveira T, Moore PL, Sigal A. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. 2022 02; 602(7898):654-656. PMID: 35016196; PMCID: PMC8866126.
    Citations: 197     Fields:    Translation:HumansAnimalsCells
  24. Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, San JE, Cromer D, Scheepers C, Amoako D, Karim F, Bernstein M, Lustig G, Archary D, Smith M, Ganga Y, Jule Z, Reedoy K, Hwa SH, Giandhari J, Blackburn JM, Gosnell BI, Abdool Karim SS, Hanekom W, von Gottberg A, Bhiman J, Lessells RJ, Moosa MS, Davenport MP, de Oliveira T, Moore PL, Sigal A. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv. 2021 Dec 17. PMID: 34909788; PMCID: PMC8669855.
    Citations: 1     
  25. Sobia P, Pillay T, Liebenberg LJP, Sivro A, Mansoor LE, Osman F, Passmore JS, Abdool Karim Q, Abdool Karim SS, Baxter C, McKinnon LR, Archary D. Higher mucosal antibody concentrations in women with genital tract inflammation. Sci Rep. 2021 12 06; 11(1):23514. PMID: 34873252; PMCID: PMC8648917.
    Citations:    Fields:    Translation:Humans
  26. Rubin EJ, Baden LR, Abdool Karim SS, Morrissey S. Audio Interview: The Omicron Variant of SARS-CoV-2. N Engl J Med. 2021 Dec 02; 385(23):e96. PMID: 34874638.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  27. Abdool Karim SS, Kelemu S, Baxter C. COVID-19 in Africa: Catalyzing change for sustainable development. PLoS Med. 2021 11; 18(11):e1003869. PMID: 34843497; PMCID: PMC8668091.
    Citations:    Fields:    Translation:Humans
  28. Mielke D, Bandawe G, Zheng J, Jones J, Abrahams MR, Bekker V, Ochsenbauer C, Garrett N, Abdool Karim S, Moore PL, Morris L, Montefiori D, Anthony C, Ferrari G, Williamson C. ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection. PLoS Pathog. 2021 11; 17(11):e1010046. PMID: 34788337.
    Citations: 3     Fields:    Translation:HumansCells
  29. Ismail SD, Riou C, Joseph SB, Archin NM, Margolis DM, Perelson AS, Cassidy T, Abrahams MR, Moeser M, Council OD, McKinnon LR, Osman F, Karim QA, Abdool Karim SS, Swanstrom R, Williamson C, Garrett NJ, Burgers WA. Immunological Correlates of the HIV-1 Replication-Competent Reservoir Size. Clin Infect Dis. 2021 10 20; 73(8):1528-1531. PMID: 34181706; PMCID: PMC8528395.
    Citations: 2     Fields:    Translation:HumansCells
  30. Mtshali A, San JE, Osman F, Garrett N, Balle C, Giandhari J, Onywera H, Mngomezulu K, Mzobe G, de Oliveira T, Rompalo A, Mindel A, Abdool Karim SS, Ravel J, Passmore JS, Abdool Karim Q, Jaspan HB, Liebenberg LJP, Ngcapu S. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis. Front Immunol. 2021; 12:730986. PMID: 34594336.
    Citations: 2     Fields:    Translation:HumansCells
  31. Jewanraj J, Ngcapu S, Osman F, Ramsuran V, Fish M, Mtshali A, Singh R, Mansoor LE, Abdool Karim SS, Abdool Karim Q, Passmore JS, Liebenberg LJP. Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection. J Int AIDS Soc. 2021 06; 24(6):e25766. PMID: 34164927; PMCID: PMC8223121.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  32. Singh R, Ramsuran V, Naranbhai V, Yende-Zuma N, Garrett N, Mlisana K, Dong KL, Walker BD, Abdool Karim SS, Carrington M, Ndung'u T. Epigenetic Regulation of BST-2 Expression Levels and the Effect on HIV-1 Pathogenesis. Front Immunol. 2021; 12:669241. PMID: 34025670; PMCID: PMC8131512.
    Citations: 2     Fields:    Translation:HumansCells
  33. Pillay K, Lewis L, Rambaran S, Yende-Zuma N, Archary D, Gengiah S, Govender D, Hassan-Moosa R, Samsunder N, Abdool Karim SS, McKinnon LR, Padayatchi N, Naidoo K, Sivro A. Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa. Front Immunol. 2021; 12:631094. PMID: 33841412.
    Citations:    Fields:    Translation:Humans
  34. Abdool Karim SS, de Oliveira T. New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications. N Engl J Med. 2021 05 13; 384(19):1866-1868. PMID: 33761203; PMCID: PMC8008749.
    Citations: 253     Fields:    Translation:HumansCells
  35. Abdool Karim SS, de Oliveira T, Loots G. Appropriate names for COVID-19 variants. Science. 2021 03 19; 371(6535):1215. PMID: 33737481.
    Citations: 7     Fields:    Translation:HumansCells
  36. Garrett N, Mtshali A, Osman F, Masson L, McKinnon LR, Singh R, Mitchev N, Ngobese H, Kharsany ABM, Abdool Karim S, Mlisana K, Passmore JA, Rompalo A, Mindel A, Liebenberg L. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women. Sex Transm Infect. 2021 12; 97(8):555-565. PMID: 33608480.
    Citations: 1     Fields:    Translation:Humans
  37. Mahomed S, Garrett N, Baxter C, Abdool Karim Q, Abdool Karim SS. Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review. J Infect Dis. 2021 02 13; 223(3):370-380. PMID: 32604408; PMCID: PMC8508778.
    Citations: 10     Fields:    Translation:HumansCells
  38. Rubin EJ, Baden LR, Abdool Karim SS, Morrissey S. Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant. N Engl J Med. 2021 Jan 14; 384(2):e14. PMID: 33497556.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  39. Mahomed S, Garrett N, Karim QA, Zuma NY, Capparelli E, Baxter C, Gengiah T, Archary D, Samsunder N, Rose ND, Moore P, Williamson C, Barouch DH, Fast PE, Pozzetto B, Hankins C, Carlton K, Ledgerwood J, Morris L, Mascola J, Abdool Karim S. Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial. BMJ Open. 2020 11 26; 10(11):e042247. PMID: 33243815.
    Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
  40. Scheepers C, Bekker V, Anthony C, Richardson SI, Oosthuysen B, Moyo T, Kgagudi P, Kitchin D, Nonyane M, York T, Mielke D, Mabvakure BM, Sheng Z, Lambson BE, Ismail A, Garrett NJ, Abdool Karim SS, Shapiro L, Williamson C, Morris L, Moore PL. Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape. Cell Rep. 2020 11 24; 33(8):108430. PMID: 33238131.
    Citations: 4     Fields:    Translation:HumansCells
  41. Jewanraj J, Ngcapu S, Osman F, Mtshali A, Singh R, Mansoor LE, Abdool Karim SS, Abdool Karim Q, Passmore JS, Liebenberg LJP. The Impact of Semen Exposure on the Immune and Microbial Environments of the Female Genital Tract. Front Reprod Health. 2020; 2:566559. PMID: 36304709; PMCID: PMC9580648.
    Citations: 1     
  42. Baxter C, Abdool Karim Q, Abdool Karim SS. Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives. Biochem Biophys Res Commun. 2021 01 29; 538:221-225. PMID: 33143875.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  43. Cromarty R, Sigal A, Liebenberg LJ, Mckinnon LR, Abdool Karim SS, Passmore JS, Archary D. Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model. J Investig Med. 2021 01; 69(1):28-40. PMID: 33004468; PMCID: PMC7803916.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  44. Brault MA, Spiegelman D, Abdool Karim SS, Vermund SH. Correction to: Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials. Curr HIV/AIDS Rep. 2020 Oct; 17(5):577. PMID: 32601917.
    Citations: 1     Fields:    
  45. Abdool Karim Q, Abdool Karim SS. COVID-19 affects HIV and tuberculosis care. Science. 2020 07 24; 369(6502):366-368. PMID: 32703860.
    Citations: 19     Fields:    Translation:HumansPHPublic Health
  46. Fisher KL, Mabuka JM, Sivro A, Ngcapu S, Passmore JS, Osman F, Ndlovu B, Abdool Karim Q, Abdool Karim SS, Chung AW, Baxter C, Archary D. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women. Front Immunol. 2020; 11:1274. PMID: 32733445.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  47. Brault MA, Spiegelman D, Abdool Karim SS, Vermund SH. Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials. Curr HIV/AIDS Rep. 2020 06; 17(3):249-258. PMID: 32297219.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  48. Abdool Karim SS. The South African Response to the Pandemic. N Engl J Med. 2020 06 11; 382(24):e95. PMID: 32469479; PMCID: PMC7281717.
    Citations: 36     Fields:    Translation:HumansCellsPHPublic Health
  49. Abdool Karim S. Criminalisation of transmission of SARS-CoV-2: A potential challenge to controlling the outbreak in South Africa. S Afr Med J. 2020 04 22; 110(6):458-460. PMID: 32880551.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  50. Drain PK, Dorward J, Violette LR, Quame-Amaglo J, Thomas KK, Samsunder N, Ngobese H, Mlisana K, Moodley P, Donnell D, Barnabas RV, Naidoo K, Abdool Karim SS, Celum C, Garrett N. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial. Lancet HIV. 2020 04; 7(4):e229-e237. PMID: 32105625; PMCID: PMC7183312.
    Citations: 25     Fields:    Translation:HumansCells
  51. Molatlhegi RP, Liebenberg LJ, Leslie A, Noel-Romas L, Mabhula A, Mchunu N, Perner M, Birse K, Ngcapu S, Adamson JH, Govender K, Garrett NJ, Samsunder N, Burgener AD, Abdool Karim SS, Abdool Karim Q, Passmore JS, McKinnon LR. Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women. Mucosal Immunol. 2020 05; 13(3):449-459. PMID: 31896762.
    Citations: 7     Fields:    Translation:Humans
  52. Richardson SI, Lambson BE, Crowley AR, Bashirova A, Scheepers C, Garrett N, Abdool Karim S, Mkhize NN, Carrington M, Ackerman ME, Moore PL, Morris L. IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody. PLoS Pathog. 2019 12; 15(12):e1008064. PMID: 31841557.
    Citations: 24     Fields:    Translation:Humans
  53. Mielke D, Bandawe G, Pollara J, Abrahams MR, Nyanhete T, Moore PL, Thebus R, Yates NL, Kappes JC, Ochsenbauer C, Garrett N, Abdool Karim S, Tomaras GD, Montefiori D, Morris L, Ferrari G, Williamson C. Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway. Front Immunol. 2019; 10:2875. PMID: 31921139.
    Citations: 12     Fields:    Translation:HumansCells
  54. Liebenberg LJP, McKinnon LR, Yende-Zuma N, Garrett N, Baxter C, Kharsany ABM, Archary D, Rositch A, Samsunder N, Mansoor LE, Passmore JS, Abdool Karim SS, Abdool Karim Q. HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition. Nat Commun. 2019 11 19; 10(1):5227. PMID: 31745084.
    Citations: 9     Fields:    Translation:HumansCells
  55. Kharsany ABM, Cawood C, Lewis L, Yende-Zuma N, Khanyile D, Puren A, Madurai S, Baxter C, George G, Govender K, Beckett S, Samsunder N, Toledo C, Ayalew KA, Diallo K, Glenshaw M, Herman-Roloff A, Wilkinson E, de Oliveira T, Abdool Karim SS, Abdool Karim Q. Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa. JAMA Netw Open. 2019 11 01; 2(11):e1914378. PMID: 31675082.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  56. Mwatelah R, McKinnon LR, Baxter C, Abdool Karim Q, Abdool Karim SS. Mechanisms of sexually transmitted infection-induced inflammation in women: implications for HIV risk. J Int AIDS Soc. 2019 08; 22 Suppl 6:e25346. PMID: 31468677; PMCID: PMC6715949.
    Citations: 19     Fields:    Translation:Humans
  57. Cromarty R, Sigal A, Liebenberg LJP, McKinnon LR, Abdool Karim SS, Passmore JS, Archary D. Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated in vitro Model. Front Immunol. 2019; 10:1705. PMID: 31396221.
    Citations: 6     Fields:    Translation:HumansCells
  58. Abdool Karim SS. HIV-1 Epidemic Control - Insights from Test-and-Treat Trials. N Engl J Med. 2019 07 18; 381(3):286-288. PMID: 31314975.
    Citations: 30     Fields:    Translation:HumansCellsPHPublic Health
  59. Mahomed S, Garrett N, Capparelli E, Baxter C, Zuma NY, Gengiah T, Archary D, Moore P, Samsunder N, Barouch DH, Mascola J, Ledgerwood J, Morris L, Abdool Karim S. Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial. BMJ Open. 2019 07 03; 9(7):e030283. PMID: 31272988.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials